Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy
Por:
Ferrero V, Oset M, Masferrer J, Pardo E, Sorolla E, Largo S, Tormo V, Marcos M, Pardo J, Aymar N, Hortelano E, Flaquer A, Jorda E, Cordoba S, Corona J, Ferrer C, Frances A, Morillo V, Bouche A, Marin S, Cambray M, Ventura M, Perez H, Hernandez R, Martin J, Lorenzo L, Fuentes C, Zurita M, del Moral R, Munoz V, Gonzalez A, Enguix M, Martinez M, Ortiz M, Fernandez M, Cardenas E, Lozano A
Publicada:
1 dic 2019
Resumen:
Purpose Radiotherapy-induced dysfunction of the gastrointestinal tract is common in cancer patients and has a significant impact on their quality of life. In this study, we investigated the prevalence of breakthrough cancer pain (BTcP) in patients undergoing 3D pelvic radiotherapy and who had proctalgia. Methods This observational, multicenter, cross-sectional epidemiological study was performed in 13 Spanish hospitals. Data were obtained on the presence and characteristics of BTcP, demographics, common comorbidities, and treatments prescribed to the patients. Results The prevalence of BTcP in patients undergoing pelvic 3D external radiotherapy with proctalgia (N = 105) was 48.6% (95% CI 39.0-58.1%). BTcP was further characterized in 59 patients. The mean (+/- SD) intensity of the BTcP episodes was 7.45 +/- 1.47 in a visual analog scale. We found several statistically significant associations between the descriptive variables of BTcP with demographic and clinical variables associated with the tumor or the patient, such as an increased number of BTcP episodes per day depending on the presence or absence of diabetes (p = 0.001, Chi-square) or time to the onset of pain relief depending on the location of the tumor (p = 0.019, Chi-square). Fentanyl was the drug of choice in BTcP episodes for 95% of the patients. Conclusions This study demonstrated a high prevalence of BTcP prevalence in cancer patients undergoing pelvic 3D radiotherapy and with proctalgia. Although the variables determining the onset of BTcP are still unclear, our results could help in the design of future clinical studies addressing the treatment of BTcP in these patients.
Filiaciones:
Ferrero V:
Hosp Univ St Joan DAlacant, Dept Radiat Oncol, Carretera Nacl 332 Alicante Valencia S-N, Alicante 03550, Spain
Oset M:
Hosp Univ St Joan DAlacant, Dept Radiat Oncol, Carretera Nacl 332 Alicante Valencia S-N, Alicante 03550, Spain
Masferrer J:
Hosp Univ Son Espases, Dept Radiat Oncol, Palma De Mallorca, Spain
Pardo E:
Hosp Univ Araba, Dept Radiat Oncol, Vitoria, Spain
Sorolla E:
Hosp Clin Univ Valencia, Dept Radiotherapy, Valencia, Spain
Largo S:
Hosp Clin San Carlos, Dept Radiat Oncol, Madrid, Spain
Tormo V:
Hosp Univ San Juan Alicante, Alicante, Spain
Marcos M:
Hosp Univ San Juan Alicante, Alicante, Spain
Pardo J:
Hosp Univ Son Espases, Palma De Mallorca, Spain
Aymar N:
Hosp Univ Son Espases, Palma De Mallorca, Spain
Hortelano E:
Hosp Univ Araba, Vitoria, Spain
Flaquer A:
Hosp Univ Araba, Vitoria, Spain
Jorda E:
Hosp Clin Univ Valencia, Valencia, Spain
Cordoba S:
Hosp Clin San Carlos, Madrid, Spain
Corona J:
Hosp Clin San Carlos, Madrid, Spain
Ferrer C:
Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain
Frances A:
Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain
Morillo V:
Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain
Bouche A:
Consorcio Hosp Prov Castellon, Castellon de La Plana, Spain
Marin S:
Inst Catala Oncol LHospitalet, Lhospitalet De Llobregat, Spain
Cambray M:
Inst Catala Oncol LHospitalet, Lhospitalet De Llobregat, Spain
Ventura M:
Inst Catala Oncol LHospitalet, Lhospitalet De Llobregat, Spain
Perez H:
Inst Catala Oncol LHospitalet, Lhospitalet De Llobregat, Spain
Hernandez R:
Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain
Martin J:
Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain
Lorenzo L:
Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain
Fuentes C:
Hosp Univ Nuestra Senora Candelaria, Santa Cruz De Tenerife, Spain
Zurita M:
Complejo Hosp Reg Virgen de las Nieves, Granada, Spain
del Moral R:
Complejo Hosp Reg Virgen de las Nieves, Granada, Spain
Munoz V:
Hosp Meixoeiro, Vigo, Spain
Gonzalez A:
Hosp Meixoeiro, Vigo, Spain
Enguix M:
Hosp Meixoeiro, Vigo, Spain
Martinez M:
Hosp Meixoeiro, Vigo, Spain
Ortiz M:
Hosp Virgen del Rocio, Seville, Spain
Fernandez M:
Hosp Virgen del Rocio, Seville, Spain
Cardenas E:
Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain
Lozano A:
Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain
|